We're excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Daniel Blumenthal, VP of Strategy at MDClone. I talk with MDClone’s VP…
Continue Reading
Anna Bager, President and CEO of OAAA
Pharma advertising is entering a period of accelerated change. As the Food and Drug Administration increases oversight of direct‑to‑consumer promotions, marketers are rethinking how they reach patients and…
Continue Reading
Pharma faces regulations and stringent rules for transparency, but the payoff is drugs that can get to market faster and possibly at less expense.Pharma first started using artificial intelligence in the clinical and development…
Continue Reading
TrumpRx signs agreement with nine new pharma manufacturers | MobiHealthNews
Skip to main content…
Continue Reading
We're excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Philip Poulidis, CEO at Toronto-based ODAIA. Poulidis is tackling one of pharma’s…
Continue Reading
Erik Terjesen, Managing Director, Silicon Foundry, a Kearney Company
Drug shortages have surged to their highest levels in decades. In early 2024, U.S. pharmacies reported more than 323 active shortages, spanning essential generics, injectables, and…
Continue Reading
Doug Besch, Chief Product and Chief Technology Officer at OptimizeRx
Consumers are increasingly learning about potential drug therapies from advertising across the media channels they use regularly – whether it be broadcast or streaming TV,…
Continue Reading
Strategic Acquisition Overview
Aptar, a global leader in drug and consumer product dosing, dispensing, and protection technologies, has announced the strategic acquisition of Sommaplast, a specialized provider of oral dosing pharma packaging solutions based in…
Thomas Kluz, Managing Director at Niterra Ventures
What if the future of drug discovery no longer rests on bold experiments, but on disciplined partnerships where artificial intelligence becomes as indispensable to pharma as the laboratory…
Continue Reading
Nicole Ventrone, Partner at Beghou
Pharma is embracing GPT-5, shifting AI from chatbot to enterprise agent as it accelerates productivity amid regulatory challenges.
Large pharmaceutical and biotech companies have spent the last couple of years running…
Continue Reading
